‹‹63››. Santella RM, Gammon M, Terry M, et al. DNA adducts, DNA repair genotype/phenotype and cancer risk.
‹‹64››. Lauber SN, Ali S, Gooderham NJ. The cooked food derived carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity.
‹‹65››. Debruin LS, Martos PA, Josephy PD. Detection of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine) in the milk of healthy women.
‹‹66››. Lauber SN, Ali S, Gooderham NJ. The cooked food derived carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity.
‹‹67››. Debruin LS, Martos PA, Josephy PD. Detection of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine) in the milk of healthy women.
‹‹68››. Bessette EE, Yasa I, Dunbar D, Wilkens LR, Le Marchand L, Turesky RJ. Biomonitoring of carcinogenic heterocyclic aromatic amines in hair: a validation study.
‹‹69››. Grose KR, Grant JL, Bjeldanes LF, et al. Isolation of the carcinogen IQ from fried egg patties.
‹‹70››. Holland RD, Gehring T, Taylor J, Lake BG, Gooderham NJ, Turesky RJ. Formation of a mutagenic heterocyclic aromatic amine from creatinine in urine of meat eaters and vegetarians.
‹‹71››. Magagnotti C, Orsi F, Bagnati R, et al. Effect of diet on serum albumin and hemoglobin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans.
‹‹72››. Lauber SN, Gooderham NJ. The cooked meat-derived mammary carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine promotes invasive behaviour of breast cancer cells.
‹‹73››. Lauber SN, Gooderham NJ. The cooked meat-derived mammary carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine promotes invasive behaviour of breast cancer cells.
‹‹74››. Vergnaud AC, Romaguera D, Peeters PH, et al. Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Eu rope: results from the European Prospective Investigation into Nutrition and Cancer cohort study.
‹‹75››. Danilo C, Frank PG. Cholesterol and breast cancer development.
‹‹76››. Firestone RA. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells.
‹‹77››. Rudling MJ, Stahle L, Peterson CO, Skoog L. Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients.
‹‹78››. Danilo C, Frank PG. Cholesterol and breast cancer development.
‹‹79››. Antalis CJ, Arnold T, Rasool T, Lee B, Buhman KK, Siddiqui RA. High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation.
‹‹80››. Firestone RA. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells.
‹‹81››. Kitahara CM, Berrington de Gonzalez A, Freedman ND, et al. Total cholesterol and cancer risk in a large prospective study in Korea.
‹‹82››. Undela K, Srikanth V, Bansal D. Statin use and risk of breast cancer: a meta-analysis of observational studies.